Intapp CEO John T. Hall exercises options, sells shares
The chief executive’s reported option exercises and matching share sales were covered by a Rule 10b5-1 plan adopted December 15, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
John T. Hall, Intapp, Inc.’s Chief Executive Officer, exercised options for 800 shares at an exercise price of $7.45 per share and sold 800 shares at a weighted-average sale price of $36.51 per share on September 30, 2026. On October 1, he exercised options for 2,200 shares at $7.45 per share and sold 2,200 shares at $36.77 per share. The option exercises and sales were made under a Rule 10b5-1 plan adopted by Hall on December 15, 2025; the September 30 sale prices ranged from $36.50 to $36.53.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F1, F3 | 2,200 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 2,200 | $7.45 | $16K |
| Sale | Common Stock F1 | 2,200 | $36.77 | $81K |
| Exercise | Employee Stock Option (Right to Buy) F1, F3 | 800 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 800 | $7.45 | $6K |
| Sale | Common Stock F1, F2 | 800 | $36.51 | $29K |
Footnotes (3)
- F1. The option exercise and sale of shares of common stock of Intapp, Inc. was executed pursuant to a 10b5-1 plan put in place by the Reporting Person on December 15, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.50 to $36.53, inclusive. The reporting person undertakes to provide to Intapp, Inc., any security holder of Intapp, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- F3. The shares underlying this option are fully vested and exercisable as of the date hereof.
Key Figures
Key Terms
10b5-1 plan regulatory
weighted average price financial
fully vested and exercisable technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.